Market Cap 95.12M
Revenue (ttm) 0.00
Net Income (ttm) -57.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 135,000
Avg Vol 233,220
Day's Range N/A - N/A
Shares Out 21.82M
Stochastic %K 10%
Beta 5.11
Analysts Sell
Price Target $17.00

Company Profile

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 225 7696
Address:
4370 La Jolla Village Drive, Suite 1050, San Diego, United States
ScamBuster0
ScamBuster0 May. 16 at 7:33 AM
$AARD All I can say is what MORON decided to run a volunteer safety study dosing 3.2 grams of a drug (1600 mg BID) daily? Didn't anyone do a mass balance study to understand the systemic drug concentration? That's standard PK. And wasn't there any intelligent tox work to understand what is the sign of too high a dose (like the cardiac effect described that sounds an awful like lidocaine, a safe drug that avoids too high a systemic dose). The standard tox saying is "the dose makes the poison." Even aspirin at too high a dose is toxic. Don't take 3.2 grams of aspirin. The Board needs to step up and fire everyone and bring in folks who are not incompetent morons. Lee needs to go.
1 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 15 at 6:46 PM
0 · Reply
StocktwitsNews
StocktwitsNews May. 15 at 5:24 PM
AARD Stock Crashes 34% – Here’s Why This Analyst Finds It ‘Hard To Lean Into’ Aardvark At This Stage $AARD https://stocktwits.com/news/equity/markets/aard-stock-crashes-brokerages-downgrade-aardvark/cZXm52iRekd
0 · Reply
diggs24
diggs24 May. 15 at 1:38 PM
$AARD halted
0 · Reply
briefingcom
briefingcom May. 15 at 12:31 PM
$AARD: Aardvark Therapeutics (-33.2%) announces the U.S. Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101 related to the Company’s previously announced voluntary pause https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260514160540AARD&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:21 PM
$AARD (-37.0% pre) FDA places clinical hold on Aardvark Therapeutics ARD-101 drug trials https://ooc.bz/l/102448
0 · Reply
Xxxxcccemre
Xxxxcccemre May. 15 at 11:43 AM
$AARD buyer under 3$ around about at cash position
0 · Reply
mikesterz7
mikesterz7 May. 15 at 2:19 AM
$AARD Aardvark Therapeutics said the FDA’s full clinical hold applies to the ongoing late-stage HERO trial for hyperphagia in PWS patients and the associated open-label extension (OLE) study.
0 · Reply
StocktwitsNews
StocktwitsNews May. 14 at 11:07 PM
AARD Stock Plummets After Hours As Cardiac Safety Concerns Trigger FDA Hold On Late-stage Program $AARD $VTI $IWM https://stocktwits.com/news/equity/markets/aard-stock-plummets-after-hours-as-cardiac-safety-concerns-trigger-fda-hold-on-late-stage-program/cZXSEPUReSj
0 · Reply
notreload_ai
notreload_ai May. 14 at 10:00 PM
FDA halted $AARD hunger drug trials for safety issues in PWS; studies stop, stock drops 17%, company talks with FDA. https://notreload.xyz/xy/fda-clinical-hold-on-aardvark-ard-101-for-prader-willi/
0 · Reply
Latest News on AARD
Aardvark Therapeutics Inc trading resumes

2026-05-15T14:36:56.000Z - 4 days ago

Aardvark Therapeutics Inc trading resumes


Aardvark Therapeutics downgraded to Neutral from Buy at BTIG

2026-05-15T13:30:50.000Z - 4 days ago

Aardvark Therapeutics downgraded to Neutral from Buy at BTIG


Aardvark Therapeutics announces FDA clinical hold on ARD-101

2026-05-14T22:08:33.000Z - 5 days ago

Aardvark Therapeutics announces FDA clinical hold on ARD-101


Aardvark Therapeutics reports Q1 EPS (99c), consensus (91c)

2026-05-07T19:19:23.000Z - 12 days ago

Aardvark Therapeutics reports Q1 EPS (99c), consensus (91c)


Aardvark Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 12 days ago

Aardvark Therapeutics Quarterly report: Q1 2026


Aardvark Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 12 days ago

Aardvark Therapeutics Earnings release: Q1 2026


Aardvark Therapeutics files $400M mixed securities shelf

2026-03-23T21:15:11.000Z - 2 months ago

Aardvark Therapeutics files $400M mixed securities shelf


Aardvark Therapeutics reports Q4 EPS (81c), consensus (83c)

2026-03-23T20:16:52.000Z - 2 months ago

Aardvark Therapeutics reports Q4 EPS (81c), consensus (83c)


Aardvark Therapeutics Annual report: Q4 2025

Mar 23, 2026, 4:00 PM EDT - 2 months ago

Aardvark Therapeutics Annual report: Q4 2025


Aardvark Therapeutics Earnings release: Q4 2025

Mar 23, 2026, 4:00 PM EDT - 2 months ago

Aardvark Therapeutics Earnings release: Q4 2025


Aardvark Therapeutics, Inc. Investigated by the Portnoy Law Firm

Mar 11, 2026, 9:00 AM EDT - 2 months ago

Aardvark Therapeutics, Inc. Investigated by the Portnoy Law Firm


Why Is Aardvark Therapeutics Stock (AARD) Down Today?

2026-03-02T12:28:45.000Z - 2 months ago

Why Is Aardvark Therapeutics Stock (AARD) Down Today?


Aardvark Therapeutics Announces Leadership Appointments

Feb 12, 2026, 8:00 AM EST - 3 months ago

Aardvark Therapeutics Announces Leadership Appointments


Aardvark Therapeutics Quarterly report: Q3 2025

Nov 13, 2025, 4:00 PM EST - 6 months ago

Aardvark Therapeutics Quarterly report: Q3 2025


Aardvark Therapeutics Earnings release: Q3 2025

Nov 13, 2025, 4:00 PM EST - 6 months ago

Aardvark Therapeutics Earnings release: Q3 2025


Aardvark Therapeutics Transcript: Study Update

Nov 5, 2025, 5:00 PM EST - 6 months ago

Aardvark Therapeutics Transcript: Study Update


Aardvark Therapeutics Press release: Study Update

Nov 5, 2025, 5:00 PM EST - 6 months ago

Aardvark Therapeutics Press release: Study Update


Aardvark Therapeutics Slides: Corporate Presentation

Sep 3, 2025, 7:00 AM EDT - 9 months ago

Aardvark Therapeutics Slides: Corporate Presentation


Aardvark Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 6:00 PM EDT - 10 months ago

Aardvark Therapeutics Quarterly report: Q2 2025


Aardvark Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 6:00 PM EDT - 10 months ago

Aardvark Therapeutics Earnings release: Q2 2025


ScamBuster0
ScamBuster0 May. 16 at 7:33 AM
$AARD All I can say is what MORON decided to run a volunteer safety study dosing 3.2 grams of a drug (1600 mg BID) daily? Didn't anyone do a mass balance study to understand the systemic drug concentration? That's standard PK. And wasn't there any intelligent tox work to understand what is the sign of too high a dose (like the cardiac effect described that sounds an awful like lidocaine, a safe drug that avoids too high a systemic dose). The standard tox saying is "the dose makes the poison." Even aspirin at too high a dose is toxic. Don't take 3.2 grams of aspirin. The Board needs to step up and fire everyone and bring in folks who are not incompetent morons. Lee needs to go.
1 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 15 at 6:46 PM
0 · Reply
StocktwitsNews
StocktwitsNews May. 15 at 5:24 PM
AARD Stock Crashes 34% – Here’s Why This Analyst Finds It ‘Hard To Lean Into’ Aardvark At This Stage $AARD https://stocktwits.com/news/equity/markets/aard-stock-crashes-brokerages-downgrade-aardvark/cZXm52iRekd
0 · Reply
diggs24
diggs24 May. 15 at 1:38 PM
$AARD halted
0 · Reply
briefingcom
briefingcom May. 15 at 12:31 PM
$AARD: Aardvark Therapeutics (-33.2%) announces the U.S. Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101 related to the Company’s previously announced voluntary pause https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260514160540AARD&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:21 PM
$AARD (-37.0% pre) FDA places clinical hold on Aardvark Therapeutics ARD-101 drug trials https://ooc.bz/l/102448
0 · Reply
Xxxxcccemre
Xxxxcccemre May. 15 at 11:43 AM
$AARD buyer under 3$ around about at cash position
0 · Reply
mikesterz7
mikesterz7 May. 15 at 2:19 AM
$AARD Aardvark Therapeutics said the FDA’s full clinical hold applies to the ongoing late-stage HERO trial for hyperphagia in PWS patients and the associated open-label extension (OLE) study.
0 · Reply
StocktwitsNews
StocktwitsNews May. 14 at 11:07 PM
AARD Stock Plummets After Hours As Cardiac Safety Concerns Trigger FDA Hold On Late-stage Program $AARD $VTI $IWM https://stocktwits.com/news/equity/markets/aard-stock-plummets-after-hours-as-cardiac-safety-concerns-trigger-fda-hold-on-late-stage-program/cZXSEPUReSj
0 · Reply
notreload_ai
notreload_ai May. 14 at 10:00 PM
FDA halted $AARD hunger drug trials for safety issues in PWS; studies stop, stock drops 17%, company talks with FDA. https://notreload.xyz/xy/fda-clinical-hold-on-aardvark-ard-101-for-prader-willi/
0 · Reply
Blackrabbit9
Blackrabbit9 May. 13 at 6:39 PM
0 · Reply
DonCorleone77
DonCorleone77 May. 10 at 3:40 PM
$AARD Aardvark Therapeutics price target lowered to $18 from $20 at BofA BofA lowered the firm's price target on Aardvark Therapeutics to $18 from $20 and keeps a Buy rating on the shares. The firm updated the company's model post the Q1 report.
0 · Reply
focafoca99
focafoca99 May. 7 at 1:55 PM
$AARD released its Q1 2026 earnings and business update.
0 · Reply
BillionerOfKing
BillionerOfKing May. 1 at 4:25 AM
$AARD Current Stock Price: $5.43 Contracts to trade: $5.0 AARD May 15 2026 Call Entry: $1.08 Exit: $1.65 ROI: 53% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Blackrabbit9
Blackrabbit9 Apr. 20 at 5:42 PM
0 · Reply
Gunnar1
Gunnar1 Apr. 20 at 3:37 PM
$AARD I'm taking gains now. Maybe way too early, but FDA meeting regarding stopped ARD-101 trial is getting closer and I don't like a bad surprise... GLTA
0 · Reply
kubota2323
kubota2323 Apr. 15 at 5:09 PM
$AARD Balance Sheet Total Cash (mrq) 110.03M Total Cash Per Share (mrq) 5.04 Total Debt (mrq) 441k Total Debt/Equity (mrq) 0.41% Current Ratio (mrq) 10.61 Book Value Per Share (mrq) 4.89
0 · Reply
Blackrabbit9
Blackrabbit9 Apr. 15 at 2:59 PM
$AARD making strong moves under the radar
0 · Reply
kubota2323
kubota2323 Apr. 15 at 2:46 PM
$AARD adding a few bags.
0 · Reply
Gunnar1
Gunnar1 Apr. 14 at 7:20 PM
$AARD Only 121 watchers? Okay...
0 · Reply
Gunnar1
Gunnar1 Apr. 14 at 3:56 PM
0 · Reply
Gunnar1
Gunnar1 Apr. 10 at 7:54 AM
$AARD 3/3 That aside, AARD meets many criteria that are personally important to me: - Cash reserves for at least 1 year - Trading below intrinsic value - Insiders and investors collectively hold approx. 75% - No reverse splits in the past - Analysts have continued to set price targets of $6, $7, $9, and $21 following the P3 halt. Technically speaking, there is a nice price gap here. See daily chart. Nevertheless take it with a grain of salt, this is very high risk!
1 · Reply